These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 36604676)

  • 1. BETi enhance ATGL expression and its lipase activity to exert their antitumoral effects in triple-negative breast cancer (TNBC) cells.
    Rossi T; Zamponi R; Chirico M; Pisanu ME; Iorio E; Torricelli F; Gugnoni M; Ciarrocchi A; Pistoni M
    J Exp Clin Cancer Res; 2023 Jan; 42(1):7. PubMed ID: 36604676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The FoxO1-ATGL axis alters milk lipolysis homeostasis through PI3K/AKT signaling pathway in dairy goat mammary epithelial cells.
    He Q; Gao L; Zhang F; Yao W; Wu J; Song N; Luo J; Zhang Y
    J Anim Sci; 2023 Jan; 101():. PubMed ID: 37638641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BET inhibitors (BETi) influence oxidative phosphorylation metabolism by affecting mitochondrial dynamics leading to alterations in apoptotic pathways in triple-negative breast cancer (TNBC) cells.
    Rossi T; Iorio E; Chirico M; Pisanu ME; Amodio N; Cantafio MEG; Perrotta I; Colciaghi F; Fiorillo M; Gianferrari A; Puccio N; Neri A; Ciarrocchi A; Pistoni M
    Cell Prolif; 2024 Dec; 57(12):e13730. PubMed ID: 39223828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bromodomain and Extraterminal Protein Inhibition Blocks Growth of Triple-negative Breast Cancers through the Suppression of Aurora Kinases.
    Sahni JM; Gayle SS; Bonk KL; Vite LC; Yori JL; Webb B; Ramos EK; Seachrist DD; Landis MD; Chang JC; Bradner JE; Keri RA
    J Biol Chem; 2016 Nov; 291(45):23756-23768. PubMed ID: 27650498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting BCL-xL improves the efficacy of bromodomain and extra-terminal protein inhibitors in triple-negative breast cancer by eliciting the death of senescent cells.
    Gayle SS; Sahni JM; Webb BM; Weber-Bonk KL; Shively MS; Spina R; Bar EE; Summers MK; Keri RA
    J Biol Chem; 2019 Jan; 294(3):875-886. PubMed ID: 30482844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophages confer resistance to BET inhibition in triple-negative breast cancer by upregulating IKBKE.
    Qiao J; Chen Y; Mi Y; Jin H; Wang L; Huang T; Li H; Song Y; Cao J; Wu B; Wang Q; Zou Z
    Biochem Pharmacol; 2020 Oct; 180():114126. PubMed ID: 32603665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin C supplementation expands the therapeutic window of BETi for triple negative breast cancer.
    Mustafi S; Camarena V; Qureshi R; Yoon H; Volmar CH; Huff TC; Sant DW; Zheng L; Brothers SP; Wahlestedt C; Slingerland J; Wang G
    EBioMedicine; 2019 May; 43():201-210. PubMed ID: 30975544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ROS-dependent HIF1α activation under forced lipid catabolism entails glycolysis and mitophagy as mediators of higher proliferation rate in cervical cancer cells.
    Castelli S; Ciccarone F; Tavian D; Ciriolo MR
    J Exp Clin Cancer Res; 2021 Mar; 40(1):94. PubMed ID: 33706793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The BET inhibitor JQ1 selectively impairs tumour response to hypoxia and downregulates CA9 and angiogenesis in triple negative breast cancer.
    da Motta LL; Ledaki I; Purshouse K; Haider S; De Bastiani MA; Baban D; Morotti M; Steers G; Wigfield S; Bridges E; Li JL; Knapp S; Ebner D; Klamt F; Harris AL; McIntyre A
    Oncogene; 2017 Jan; 36(1):122-132. PubMed ID: 27292261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a stemness-related gene panel associated with BET inhibition in triple negative breast cancer.
    Serrano-Oviedo L; Nuncia-Cantarero M; Morcillo-Garcia S; Nieto-Jimenez C; Burgos M; Corrales-Sanchez V; Perez-Peña J; Győrffy B; Ocaña A; Galán-Moya EM
    Cell Oncol (Dordr); 2020 Jun; 43(3):431-444. PubMed ID: 32166583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid droplets induced by secreted phospholipase A
    Jarc E; Kump A; Malavašič P; Eichmann TO; Zimmermann R; Petan T
    Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Mar; 1863(3):247-265. PubMed ID: 29229414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocyte-specific deletion of adipose triglyceride lipase (adipose triglyceride lipase/patatin-like phospholipase domain containing 2) ameliorates dietary induced steatohepatitis in mice.
    Fuchs CD; Radun R; Dixon ED; Mlitz V; Timelthaler G; Halilbasic E; Herac M; Jonker JW; Ronda OAHO; Tardelli M; Haemmerle G; Zimmermann R; Scharnagl H; Stojakovic T; Verkade HJ; Trauner M
    Hepatology; 2022 Jan; 75(1):125-139. PubMed ID: 34387896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of BET-proteolysis targeting chimeric (PROTAC) compounds in triple negative breast cancer.
    Noblejas-López MDM; Nieto-Jimenez C; Burgos M; Gómez-Juárez M; Montero JC; Esparís-Ogando A; Pandiella A; Galán-Moya EM; Ocaña A
    J Exp Clin Cancer Res; 2019 Aug; 38(1):383. PubMed ID: 31470872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ATGL lipase cooperates with ABHD5 to mobilize lipids for hepatitis C virus assembly.
    Vieyres G; Reichert I; Carpentier A; Vondran FWR; Pietschmann T
    PLoS Pathog; 2020 Jun; 16(6):e1008554. PubMed ID: 32542055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adipose Triglyceride Lipase Is a Therapeutic Target in Advanced Prostate Cancer That Promotes Metabolic Plasticity.
    Awad D; Cao PHA; Pulliam TL; Spradlin M; Subramani E; Tellman TV; Ribeiro CF; Muzzioli R; Jewell BE; Pakula H; Ackroyd JJ; Murray MM; Han JJ; Leng M; Jain A; Piyarathna B; Liu J; Song X; Zhang J; Klekers AR; Drake JM; Ittmann MM; Coarfa C; Piwnica-Worms D; Farach-Carson MC; Loda M; Eberlin LS; Frigo DE
    Cancer Res; 2024 Mar; 84(5):703-724. PubMed ID: 38038968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adipose triglyceride lipase activity regulates cancer cell proliferation via AMP-kinase and mTOR signaling.
    Xie H; Heier C; Kien B; Vesely PW; Tang Z; Sexl V; Schoiswohl G; Strießnig-Bina I; Hoefler G; Zechner R; Schweiger M
    Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Sep; 1865(9):158737. PubMed ID: 32404277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adipose triglyceride lipase activity is inhibited by long-chain acyl-coenzyme A.
    Nagy HM; Paar M; Heier C; Moustafa T; Hofer P; Haemmerle G; Lass A; Zechner R; Oberer M; Zimmermann R
    Biochim Biophys Acta; 2014 Apr; 1841(4):588-94. PubMed ID: 24440819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of
    Li J; Wang Y; Yang P; Han H; Zhang G; Xu H; Quan K
    Anim Biotechnol; 2023 Dec; 34(7):3126-3134. PubMed ID: 36306180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utilization of adipocyte-derived lipids and enhanced intracellular trafficking of fatty acids contribute to breast cancer progression.
    Yang D; Li Y; Xing L; Tan Y; Sun J; Zeng B; Xiang T; Tan J; Ren G; Wang Y
    Cell Commun Signal; 2018 Jun; 16(1):32. PubMed ID: 29914512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of adipose triglyceride lipase protects from hepatic endoplasmic reticulum stress in mice.
    Fuchs CD; Claudel T; Kumari P; Haemmerle G; Pollheimer MJ; Stojakovic T; Scharnagl H; Halilbasic E; Gumhold J; Silbert D; Koefeler H; Trauner M
    Hepatology; 2012 Jul; 56(1):270-80. PubMed ID: 22271167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.